Identification and experimental validation of biomarkers associated with macrophages in myocardial

Xiaojie Jiang1, Liyun Liu1, Jianxin Huang1

  • 1Department of Cardiology, The First Hospital of Nanchang, Nanchang, China.

Scientific Reports
|December 5, 2025
PubMed

Insights

This study identifies Tlr7, Tlr1, Tlr6, and Il33 as key macrophage-associated biomarkers for myocardial ischemia-reperfusion injury (MIRI). These findings offer insights into MIRI mechanisms and potential therapeutic targets for improved patient outcomes.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Myocardial ischemia-reperfusion injury (MIRI) causes significant heart damage.
  • Macrophages are crucial in tissue repair and homeostasis, influencing MIRI outcomes.

Purpose of the Study:

  • To identify macrophage-related genes (MRGs) as biomarkers for MIRI.
  • To explore the molecular mechanisms and regulatory networks of these biomarkers in MIRI.

Main Methods:

  • Integrated transcriptomic data with MRGs to identify candidate genes.
  • Utilized protein-protein interaction analysis, enrichment analysis, and immune infiltration analysis.
  • Validated findings using RT-qPCR and analyzed single-cell data for biomarker distribution.

Main Results:

  • Identified Tlr7, Tlr1, Tlr6, and Il33 as key macrophage-associated biomarkers in MIRI.
  • Found significant enrichment in "Ribosome," "Oxidative phosphorylation," and "Spliceosome" pathways.
  • Tlr7, Tlr1, and Tlr6 showed positive correlations with macrophage subtypes and were upregulated in MIRI; Tlr7 and Tlr1 were mainly expressed in M2 macrophages.

Conclusions:

  • Tlr7, Tlr1, Tlr6, and Il33 are valuable macrophage-associated biomarkers for MIRI diagnosis.
  • Identified potential therapeutic targets, including IMIQUIMOD and Acetaminophen, for MIRI treatment.
  • The study provides a foundation for understanding macrophage roles in MIRI pathogenesis and developing targeted therapies.